Russell Investments Group Ltd. Reduces Holdings in Option Care Health, Inc. (NASDAQ:OPCH)

Russell Investments Group Ltd. decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 42.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 113,980 shares of the company’s stock after selling 85,499 shares during the period. Russell Investments Group Ltd.’s holdings in Option Care Health were worth $2,644,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also made changes to their positions in OPCH. Wellington Management Group LLP boosted its stake in shares of Option Care Health by 84.6% during the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company’s stock worth $425,143,000 after purchasing an additional 8,400,208 shares during the period. Norges Bank purchased a new position in shares of Option Care Health during the fourth quarter valued at approximately $60,219,000. Victory Capital Management Inc. boosted its position in shares of Option Care Health by 31.1% during the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company’s stock valued at $49,310,000 after buying an additional 503,840 shares during the period. Magnetar Financial LLC grew its stake in shares of Option Care Health by 23.1% during the fourth quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company’s stock valued at $54,534,000 after buying an additional 441,265 shares during the last quarter. Finally, Trexquant Investment LP purchased a new stake in shares of Option Care Health in the fourth quarter worth approximately $10,161,000. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Insider Buying and Selling

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. 0.64% of the stock is currently owned by insiders.

Wall Street Analysts Forecast Growth

OPCH has been the topic of several research analyst reports. JPMorgan Chase & Co. upped their price objective on Option Care Health from $40.00 to $41.00 and gave the company an “overweight” rating in a research report on Thursday, March 6th. Barrington Research upped their price target on shares of Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. Jefferies Financial Group upgraded shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their price objective for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. Bank of America upgraded shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their target price for the stock from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 price target (down previously from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, Option Care Health currently has an average rating of “Moderate Buy” and a consensus target price of $33.00.

Option Care Health Trading Down 0.6 %

NASDAQ:OPCH opened at $32.09 on Friday. The firm has a 50-day simple moving average of $33.32 and a 200-day simple moving average of $28.64. Option Care Health, Inc. has a one year low of $21.39 and a one year high of $35.53. The firm has a market cap of $5.27 billion, a P/E ratio of 26.96, a P/E/G ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.